Funded Biotech startups in Connecticut
3 biotech startups in Connecticut have filed a Form D with the SEC and together report $38.1M raised. Allyx Therapeutics has the largest latest round, at $26.4M. Amounts are as reported on the filing, not estimates.
Updated May 11, 2026
- Companies
- 3
- Total raised
- $38.1M
- Filings
- 4
- Median round
- $5.0M
- Cities
- 3
CompanyCityLast filingLatest round
OncosynergyBeta-1 integrin antibody for recurrent glioblastoma
Stamford
May 11, 2026
$6.6M
Allyx TherapeuticsOral drug to protect synapses in Alzheimer's
New Haven
May 4, 2026
$26.4M
Formulary FinancialMarket access research for drug makers
Weston
Mar 20, 2025
$1.7M
All 3 companies · most recent filing first
Most recent filings
3All 3 companies · most recent filing first